Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 0	$ 0
Operating expenses
Research and development	1,054,293	192,773
General and administrative	(537,044)	1,035,566
Total operating expenses, net	517,249	1,228,339
Loss from operations	(517,249)	(1,228,339)
Other income
Interest income	7	53,586
Total other income	7	53,586
Net loss	$ (517,242)	$ (1,174,753)
Basic and Diluted Loss per Common Share	$ (0.01)	$ (0.01)
Weighted average number of common shares outstanding - basic and diluted	87,352,364	87,352,364